<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Information on the change in extracellular <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> (AA) during the <z:hpo ids='HP_0011009'>acute</z:hpo> period of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is of great importance in the early therapeutic intervention of the cerebral ischemic injury since AA is known to be involved into most kinds of neurochemical changes in the <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This study describes a fast and efficient method through integration of in vivo microdialysis with on-line electrochemical detection for continuous monitoring cerebral AA, allowing comparative study of the change in the extracellular AA level in different <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>/reperfusion models </plain></SENT>
<SENT sid="2" pm="."><plain>The method exhibits a high specificity for AA measurements, bearing a good tolerance against the fluctuation in the brain <z:mp ids='MP_0002316'>anoxia</z:mp> and acidity induced by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>In the global two-vessel occlusion (2-VO) <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model, the striatum AA did not change with statistic significance until 60 min after occlusion and was decreased to be 91+/-3% (n=5, P&lt;0.05) of the basal level (8.05+/-0.23 microM) at the time point of 60 min after occlusion </plain></SENT>
<SENT sid="4" pm="."><plain>In the 2-VO <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion model, AA remained unchanged during the 10 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and was sharply increased to be 267+/-74% (n=5, P&lt;0.05) of the basal level after the initial 15 min of reperfusion, and then decreased to be 122+/-33% (n=5, P&lt;0.05) of the basal level after 50 min of reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Extracellular AA was largely increased after 5 min of left middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (LMCAO) and was then gradually increased to be 257+/-49% (n=5, P&lt;0.05) of the basal level after 60 min of LMCAO <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In the LMCAO <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion model, AA was greatly increased during 10 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and then gradually increased to be 309+/-69% (n=5, P&lt;0.05) of the basal level after the consecutive 50 min of reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain>The results demonstrated here may be useful for understanding the neurochemical processes in the <z:hpo ids='HP_0011009'>acute</z:hpo> period of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and could thus be important for neuroprotective therapeutics for cerebral ischemic injury </plain></SENT>
</text></document>